ColdZyme® protects airway epithelia from infection with BA.4/5.

Respir Res · 2022 · PMC9624019 · PMID 36316674

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

We found highly significant differences in cell numbers and percentages of C3 + - (Fig. 1 e) cells between cultures infected with the two SARS-CoV-2-VOCs compared to ColdZyme-treated/uninfected and ColdZyme®-treated/SARS-CoV-2-VOC-infected, primary respiratory cultures.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.